COVID-19疫苗接种后心肌炎和心包炎的心脏磁共振成像:27例多中心病例集
回顾性收集16家大型三级中心27例COVID-19疫苗接种后疑似心脏炎症并接受心脏磁共振检查的患者(36.6±16.8岁,男性25/27)。心脏磁共振在23例显示典型的中-心外膜下非缺血性晚期钆增强,并与心肌炎T2标准阳性匹配;7例有急性心包炎典型特征。中位随访20天,25/27例无事件。
要点
- COVID-19疫苗接种后出现急性呼吸困难、心悸或持续胸痛应怀疑心肌炎或心包炎可能。
- 肌钙蛋白升高和/或相关心电图改变时,可考虑心脏磁共振作为确认诊断的最佳无创选项。
- 心脏磁共振显示中-心外膜下非缺血性晚期钆增强是心肌炎的典型表现。
核心结论
- 虽然确定心包心肌炎症与疫苗接种之间的因果关系可能具有挑战性,但作者的临床经验提示,心脏磁共振应进行以确认诊断并指导临床决策和随访。
关键影像表现/征象
- 心脏磁共振在23例显示典型的中-心外膜下非缺血性晚期钆增强(LGE)。
- 23例中LGE与心肌炎心脏磁共振T2标准阳性匹配。
- 7例存在急性心包炎典型特征。
诊断标准与关键数值
- 心脏磁共振显示中-心外膜下非缺血性晚期钆增强为心肌炎典型表现。
- 心脏磁共振T2标准用于心肌炎诊断。
- 急性心包炎典型特征用于心包炎诊断。
临床应用与阅片要点
- COVID-19疫苗接种后急性起病的呼吸困难、心悸或急性持续胸痛应怀疑心肌炎或心包炎可能,患者应寻求立即医疗关注和治疗。
- 肌钙蛋白水平升高和/或相关心电图改变时,可考虑心脏磁共振作为确认心肌炎或心包炎诊断的最佳无创诊断选项,并指导临床决策和随访。
- 作者认为心脏磁共振应进行以确认诊断并指导临床决策和随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess clinical and cardiac magnetic resonance (CMR) imaging features of patients with peri-myocarditis following Coronavirus Disease 2019 (COVID-19) vaccination.
METHODS: We retrospectively collected a case series of 27 patients who underwent CMR in the clinical suspect of heart inflammation following COVID-19 vaccination, from 16 large tertiary centers. Our patient's cohort was relatively young (36.6 ± 16.8 years), predominately included males (n = 25/27) with few comorbidities and covered a catchment area of approximately 8 million vaccinated patients.
RESULTS: CMR revealed typical mid-subepicardial non-ischemic late gadolinium enhancement (LGE) in 23 cases and matched positively with CMR T2 criteria of myocarditis. In 7 cases, typical hallmarks of acute pericarditis were present. Short-term follow-up (median = 20 days) from presentation was uneventful for 25/27 patients and unavailable in two cases.
CONCLUSIONS: While establishing a causal relationship between peri-myocardial inflammation and vaccine administration can be challenging, our clinical experience suggests that CMR should be performed for diagnosis confirmation and to drive clinical decision-making and follow-up.
KEY POINTS: • Acute onset of dyspnea, palpitations, or acute and persisting chest pain after COVID-19 vaccination should raise the suspicion of possible myocarditis or pericarditis, and patients should seek immediate medical attention and treatment to help recovery and avoid complications. • In case of elevated troponin levels and/or relevant ECG changes, cardiac magnetic resonance should be considered as the best non-invasive diagnostic option to confirm the diagnosis of myocarditis or pericarditis and to drive clinical decision-making and follow-up.
引用
- Di Dedda, Barison, Aquaro, et al. Cardiac magnetic resonance imaging of myocarditis and pericarditis following COVID-19 vaccination: a multicenter collection of 27 cases. Eur Radiol. 2022. PMID: 35230520. doi:10.1007/s00330-022-08566-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。